TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets

Neumann, 2006, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130, 10.1126/science.1134108

Ling, 2013, Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis, Neuron, 79, 416, 10.1016/j.neuron.2013.07.033

Arai, 2006, TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Biochem Biophys Res Commun, 351, 602, 10.1016/j.bbrc.2006.10.093

Ou, 1995, Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs, J Virol, 69, 3584, 10.1128/jvi.69.6.3584-3596.1995

Winton, 2008, Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation, J Biol Chem, 283, 13302, 10.1074/jbc.M800342200

Buratti, 2005, TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing, J Biol Chem, 280, 37572, 10.1074/jbc.M505557200

Hebron, 2013, Parkin ubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6), J Biol Chem, 288, 4103, 10.1074/jbc.M112.419945

Gregory, 2004, The microprocessor complex mediates the genesis of microRNAs, Nature, 432, 235, 10.1038/nature03120

Xu, 2012, Does a loss of TDP-43 function cause neurodegeneration?, Mol Neurodegener, 7, 27, 10.1186/1750-1326-7-27

Polymenidou, 2011, Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43, Nat Neurosci, 14, 459, 10.1038/nn.2779

Ayala, 2011, TDP-43 regulates its mRNA levels through a negative feedback loop, EMBO J, 30, 277, 10.1038/emboj.2010.310

Tollervey, 2011, Characterizing the RNA targets and position-dependent splicing regulation by TDP-43, Nat Neurosci, 14, 452, 10.1038/nn.2778

Carlomagno, 2014, Casein kinase II induced polymerization of soluble TDP-43 into filaments is inhibited by heat shock proteins, PLoS One, 9, e90452, 10.1371/journal.pone.0090452

Al-Sarraj, 2011, p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS, Acta Neuropathol, 122, 691, 10.1007/s00401-011-0911-2

Bose, 2011, Regulation of autophagy by neuropathological protein TDP-43, J Biol Chem, 286, 44441, 10.1074/jbc.M111.237115

Barmada, 2010, Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis, J Neurosci, 30, 639, 10.1523/JNEUROSCI.4988-09.2010

Diaper, 2013, Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes, Hum Mol Genet, 22, 1539, 10.1093/hmg/ddt005

Alami, 2014, Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations, Neuron, 81, 536, 10.1016/j.neuron.2013.12.018

Liu-Yesucevitz, 2014, ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor, J Neurosci, 34, 4167, 10.1523/JNEUROSCI.2350-13.2014

Colombrita, 2009, TDP-43 is recruited to stress granules in conditions of oxidative insult, J Neurochem, 111, 1051, 10.1111/j.1471-4159.2009.06383.x

Lindquist, 1981, Regulation of protein synthesis during heat shock, Nature, 293, 311, 10.1038/293311a0

Mackenzie, 2007, Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations, Ann Neurol, 61, 427, 10.1002/ana.21147

Maekawa, 2009, TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations, Neuropathology, 29, 672, 10.1111/j.1440-1789.2009.01029.x

Mackenzie, 2007, Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations, Ann Neurol, 61, 427, 10.1002/ana.21147

Tan, 2007, TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation, Acta Neuropathol, 113, 535, 10.1007/s00401-007-0206-9

Tateishi, 2010, Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation, Acta Neuropathol, 119, 355, 10.1007/s00401-009-0621-1

Vance, 2009, Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6, Science, 323, 1208, 10.1126/science.1165942

Suzuki, 2010, FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion, J Hum Genet, 55, 252, 10.1038/jhg.2010.16

Kwong, 2007, TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease, Acta Neuropathol, 114, 63, 10.1007/s00401-007-0226-5

Brettschneider, 2013, Stages of pTDP-43 pathology in amyotrophic lateral sclerosis, Ann Neurol, 74, 20, 10.1002/ana.23937

Wils, 2010, TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration, Proc Natl Acad Sci U S A, 107, 3858, 10.1073/pnas.0912417107

Li, 2010, A Drosophila model for TDP-43 proteinopathy, Proc Natl Acad Sci U S A, 107, 3169, 10.1073/pnas.0913602107

Ash, 2010, Neurotoxic effects of TDP-43 overexpression in C. elegans, Hum Mol Genet, 19, 3206, 10.1093/hmg/ddq230

Wu, 2010, TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis, Genesis, 48, 56, 10.1002/dvg.20584

Sephton, 2010, TDP-43 is a developmentally regulated protein essential for early embryonic development, J Biol Chem, 285, 6826, 10.1074/jbc.M109.061846

Kraemer, 2010, Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis, Acta Neuropathol, 119, 409, 10.1007/s00401-010-0659-0

Wu, 2012, Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice, J Biol Chem, 287, 27335, 10.1074/jbc.M112.359000

Iguchi, 2013, Loss of TDP-43 causes age-dependent progressive motor neuron degeneration, Brain, 136, 1371, 10.1093/brain/awt029

Kabashi, 2010, Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo, Hum Mol Genet, 19, 671, 10.1093/hmg/ddp534

Yang, 2014, Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis, Proc Natl Acad Sci U S A, 111, E1121

Diaper, 2013, Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD, Hum Mol Genet, 22, 3883, 10.1093/hmg/ddt243

Renton, 2014, State of play in amyotrophic lateral sclerosis genetics, Nat Neurosci, 17, 17, 10.1038/nn.3584

Sreedharan, 2008, TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis, Science, 319, 1668, 10.1126/science.1154584

Van Deerlin, 2008, TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis, Lancet Neurol, 7, 409, 10.1016/S1474-4422(08)70071-1

Rutherford, 2008, Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis, PLoS Genet, 4, e1000193, 10.1371/journal.pgen.1000193

Kabashi, 2008, TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis, Nat Genet, 40, 572, 10.1038/ng.132

Abel, 2012, ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics, Hum Mutat, 33, 1345, 10.1002/humu.22157

Corrado, 2009, High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis, Hum Mutat, 30, 688, 10.1002/humu.20950

Kirby, 2010, Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis, Neurogenetics, 11, 217, 10.1007/s10048-009-0218-9

Xiong, 2010, Association between novel TARDBP mutations and Chinese patients with amyotrophic lateral sclerosis, BMC Med Genet, 11, 8, 10.1186/1471-2350-11-8

Zou, 2012, Screening of the TARDBP gene in familial and sporadic amyotrophic lateral sclerosis patients of Chinese origin, Neurobiol Aging, 33, 2229 e11, 10.1016/j.neurobiolaging.2012.03.014

Del Bo, 2009, TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations, Eur J Neurol, 16, 727, 10.1111/j.1468-1331.2009.02574.x

Lemmens, 2009, TDP-43 M311V mutation in familial amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 80, 354, 10.1136/jnnp.2008.157677

Baumer, 2009, TARDBP in amyotrophic lateral sclerosis: identification of a novel variant but absence of copy number variation, J Neurol Neurosurg Psychiatry, 80, 1283, 10.1136/jnnp.2008.166512

Yokoseki, 2008, TDP-43 mutation in familial amyotrophic lateral sclerosis, Ann Neurol, 63, 538, 10.1002/ana.21392

Kuhnlein, 2008, Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations, Arch Neurol, 65, 1185, 10.1001/archneur.65.9.1185

Daoud, 2009, Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis, J Med Genet, 46, 112, 10.1136/jmg.2008.062463

Origone, 2010, Enlarging clinical spectrum of FALS with TARDBP gene mutations: S393L variant in an Italian family showing phenotypic variability and relevance for genetic counselling, Amyotroph Lateral Scler, 11, 223, 10.3109/17482960903165039

Arnold, 2013, ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43, Proc Natl Acad Sci U S A, 110, E736, 10.1073/pnas.1222809110

Bilican, 2012, Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability, Proc Natl Acad Sci U S A, 109, 5803, 10.1073/pnas.1202922109

Serio, 2013, Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy, Proc Natl Acad Sci U S A, 110, 4697, 10.1073/pnas.1300398110

Han, 2013, ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons, Exp Cell Res, 319, 1998, 10.1016/j.yexcr.2013.05.025

Nonaka, 2009, Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43, Hum Mol Genet, 18, 3353, 10.1093/hmg/ddp275

Johnson, 2009, TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity, J Biol Chem, 284, 20329, 10.1074/jbc.M109.010264

Budini, 2012, Role of selected mutations in the Q/N rich region of TDP-43 in EGFP-12xQ/N-induced aggregate formation, Brain Res, 1462, 139, 10.1016/j.brainres.2012.02.031

Barmada, 2014, Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models, Nat Chem Biol, 10, 677, 10.1038/nchembio.1563

Ling, 2010, ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS, Proc Natl Acad Sci U S A, 107, 13318, 10.1073/pnas.1008227107

Watanabe, 2013, Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins, J Biol Chem, 288, 3641, 10.1074/jbc.M112.433615

Wu, 2013, Similar dose-dependence of motor neuron cell death caused by wild type human TDP-43 and mutants with ALS-associated amino acid substitutions, J Biomed Sci, 20, 33, 10.1186/1423-0127-20-33

Nishimura, 2014, Allele-specific knockdown of ALS-associated mutant TDP-43 in neural stem cells derived from induced pluripotent stem cells, PLoS One., 9, e91269, 10.1371/journal.pone.0091269

Miller, 2013, An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study, Lancet Neurol, 12, 435, 10.1016/S1474-4422(13)70061-9

Fecto, 2012, SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis, Arch Neurol, 68, 1440, 10.1001/archneurol.2011.250

Watts, 2004, Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein, Nat Genet, 36, 377, 10.1038/ng1332

Deng, 2011, Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia, Nature, 477, 211, 10.1038/nature10353

Maruyama, 2010, Mutations of optineurin in amyotrophic lateral sclerosis, Nature, 465, 223, 10.1038/nature08971

Ju, 2009, Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease, J Cell Biol, 187, 875, 10.1083/jcb.200908115

Tresse, 2010, VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD, Autophagy, 6, 217, 10.4161/auto.6.2.11014

Seibenhener, 2004, Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation, Mol Cell Biol, 24, 8055, 10.1128/MCB.24.18.8055-8068.2004

Pankiv, 2007, p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy, J Biol Chem, 282, 24131, 10.1074/jbc.M702824200

Kleijnen, 2000, The hPLIC Proteins may provide a link between the ubiquitination machinery and the proteasome, Mol Cell, 6, 409, 10.1016/S1097-2765(00)00040-X

N'Diaye, 2009, PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation, EMBO Rep, 10, 173, 10.1038/embor.2008.238

Wild, 2011, Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth, Science, 333, 228, 10.1126/science.1205405

Scotter, 2014, Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species, J Cell Sci, 127, 1263

Caccamo, 2009, Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability, J Biol Chem, 284, 27416, 10.1074/jbc.M109.031278

Urushitani, 2010, Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43, J Neurosci Res, 88, 784, 10.1002/jnr.22243

Wang, 2010, Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system, Neurosci Lett, 469, 112, 10.1016/j.neulet.2009.11.055

Zhang, 2009, Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity, Proc Natl Acad Sci U S A, 106, 7607, 10.1073/pnas.0900688106

Wojcik, 2004, RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis, J Cell Sci, 117, 281, 10.1242/jcs.00841

Lamark, 2009, Autophagy: links with the proteasome, Curr Opin Cell Biol, 22, 192, 10.1016/j.ceb.2009.11.002

Thomas, 2013, RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum, Brain, 136, 1345, 10.1093/brain/awt030

Lamark, 2012, Aggrephagy: selective disposal of protein aggregates by macroautophagy, Int J Cell Biol, 2012, 736905, 10.1155/2012/736905

Kopito, 2000, Aggresomes, inclusion bodies and protein aggregation, Trends Cell Biol, 10, 524, 10.1016/S0962-8924(00)01852-3

Colby, 2006, Stochastic kinetics of intracellular huntingtin aggregate formation, Nat Chem Biol, 2, 319, 10.1038/nchembio792

Jarrett, 1993, Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?, Cell, 73, 1055, 10.1016/0092-8674(93)90635-4

Wood, 1999, α-Synuclein fibrillogenesis is nucleation-dependent: Implications for the pathogenesis of Parkinsonatidisease, J Biol Chem, 274, 19509, 10.1074/jbc.274.28.19509

King, 2012, The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease, Brain Res, 1462, 61, 10.1016/j.brainres.2012.01.016

Johnson, 2010, Exome sequencing reveals VCP mutations as a cause of familial ALS, Neuron, 68, 857, 10.1016/j.neuron.2010.11.036

Lee, 2010, Enhancement of proteasome activity by a small-molecule inhibitor of USP14, Nature, 467, 179, 10.1038/nature09299

Wang, 2012, Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43, Proc Natl Acad Sci U S A, 109, 15024, 10.1073/pnas.1206362109

Lagier-Tourenne, 2012, Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs, Nat Neurosci, 15, 1488, 10.1038/nn.3230

Honda, 2013, The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons, FEBS Open Bio, 4, 1, 10.1016/j.fob.2013.11.001

DeJesus-Hernandez, 2011, Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS, Neuron, 72, 245, 10.1016/j.neuron.2011.09.011

Renton, 2011, A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD, Neuron, 72, 257, 10.1016/j.neuron.2011.09.010

Lee, 2013, Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic, Cell Rep, 5, 1178, 10.1016/j.celrep.2013.10.049

Cooper-Knock, 2014, Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions, Brain, 137, 2040, 10.1093/brain/awu120

Lagier-Tourenne, 2013, Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration, Proc Natl Acad Sci U S A, 110, E4530, 10.1073/pnas.1318835110

Donnelly, 2013, RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention, Neuron, 80, 415, 10.1016/j.neuron.2013.10.015

Troakes, 2012, An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline, Neuropathology, 32, 505, 10.1111/j.1440-1789.2011.01286.x

Brettschneider, 2012, Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion, Acta Neuropathol, 123, 825, 10.1007/s00401-012-0970-z

Mann, 2013, Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72, Acta Neuropathol Commun, 1, 68, 10.1186/2051-5960-1-68

Ash, 2013, Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS, Neuron, 77, 639, 10.1016/j.neuron.2013.02.004

Mori, 2013, The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS, Science, 339, 1335, 10.1126/science.1232927

Kwon, 2014, Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells, Science, 345, 1139, 10.1126/science.1254917

Mizielinska, 2014, C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins, Science, 345, 1192, 10.1126/science.1256800

Yamakawa M, Ito D, Honda T, et al. Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS. Hum Mol Genet 2014 Nov 14 [Epub ahead of print].

May, 2014, C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration, Acta Neuropathol, 128, 485, 10.1007/s00401-014-1329-4

Davidson, 2014, Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72, Acta Neuropathol Commun, 2, 70, 10.1186/2051-5960-2-70

Mackenzie, 2013, Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations, Acta Neuropathol, 126, 859, 10.1007/s00401-013-1181-y

Su, 2014, Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS, Neuron, 83, 1043, 10.1016/j.neuron.2014.07.041

Zamiri, 2014, TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins, J Biol Chem, 289, 4653, 10.1074/jbc.C113.502336

Johnson, 2014, Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis, Nat Neurosci, 17, 664, 10.1038/nn.3688

Kim, 2013, Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS, Nature, 495, 467, 10.1038/nature11922

Kusui, 1962, Epidemiological study on amyotrophic lateral sclerosis (ALS) and other neighboring motor neuron diseases in Kii Peninsula, Seishin Shinkeigaku Zasshi, 64, 85

Huang, 2014, Metabolism and mis-metabolism of the neuropathological signature protein TDP-43, J Cell Sci, 127, 3024

Ishiura, 2012, C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan, Arch Neurol, 69, 1154, 10.1001/archneurol.2012.1219

Smith Bradley, 2014, Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS, Neuron, 84, 324, 10.1016/j.neuron.2014.09.027

Smith BN, Vance C, Scotter EL, et al. Novel mutations support a role for Profilin1 in the pathogenesis of ALS. Neurobiol Aging 2014 Oct 31 [Epub ahead of print].

Sieh, 2009, Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates, Hum Mol Genet, 18, 3725, 10.1093/hmg/ddp300

Jansson, 2014, A role for human brain pericytes in neuroinflammation, J Neuroinflammation, 11, 104, 10.1186/1742-2094-11-104

Synofzik, 2014, Targeted high-throughput sequencing identifies a TARDBP mutation as a cause of early-onset FTD without motor neuron disease, Neurobiol Aging, 35, 1212 e1, 10.1016/j.neurobiolaging.2013.10.092

Johnson RT, Bradley W, Ritz B, Rocca WA, Shefner J, Wolfson C. Amyotrophic lateral sclerosis in veterans: Review of the scientific literature. United States of America: The National Academies Press, 2006, Report No.: 9780309102544.

Mizielinska, 2013, C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci, Acta Neuropathol, 126, 845, 10.1007/s00401-013-1200-z

Chio, 2009, ALS in Italian professional soccer players: the risk is still present and could be soccer-specific, Amyotroph Lateral Scler, 10, 205, 10.1080/17482960902721634

Orrell, 2008, A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease, Amyotroph Lateral Scler, 9, 195, 10.1080/17482960801900032

Polling, 2014, Misfolded polyglutamine, polyalanine, and superoxide dismutase 1 aggregate via distinct pathways in the cell, J Biol Chem, 289, 6669, 10.1074/jbc.M113.520189

Dewey CM, Cenik B, Sephton CF, et al. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol 2010:MCB.01279-10.

Liu-Yesucevitz, 2010, Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue, PLoS One, 5, e13250, 10.1371/journal.pone.0013250

McDonald, 2011, TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1, Hum Mol Genet, 20, 1400, 10.1093/hmg/ddr021

Udan-Johns, 2014, Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones, Hum Mol Genet, 23, 157, 10.1093/hmg/ddt408

Dormann, 2011, TDP-43 and FUS: a nuclear affair, Trends Neurosci, 34, 339, 10.1016/j.tins.2011.05.002

Kim, 2014, Therapeutic modulation of eIF2alpha phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models, Nat Genet, 46, 152, 10.1038/ng.2853

Meyerowitz, 2011, C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress, Mol Neurodegener, 6, 57, 10.1186/1750-1326-6-57

Bentmann, 2012, Requirements for stress granule recruitment of fused in Sarcoma (FUS) and TAR DNA binding protein of 43 kDa (TDP-43), J Biol Chem, 287, 23079, 10.1074/jbc.M111.328757

Dormann, 2010, ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import, EMBO J, 29, 2841, 10.1038/emboj.2010.143

Zhou, 2010, Transgenic rat model of neurodegeneration caused by mutation in the TDP gene, PLoS Genet, 6, e1000887, 10.1371/journal.pgen.1000887

De Marco, 2011, Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations, Acta Neuropathol, 121, 611, 10.1007/s00401-010-0786-7

van Eersel, 2011, Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons, PLoS One, 6, e22850, 10.1371/journal.pone.0022850

Igaz, 2011, Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice, J Clin Invest, 121, 726, 10.1172/JCI44867

Igaz, 2008, Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Am J Pathol, 173, 182, 10.2353/ajpath.2008.080003

Suzuki, 2011, TDP-43-induced death is associated with altered regulation of BIM and Bcl-xL and attenuated by caspase-mediated TDP-43 cleavage, J Biol Chem, 286, 13171, 10.1074/jbc.M110.197483

Dormann, 2009, Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin, J Neurochem, 110, 1082, 10.1111/j.1471-4159.2009.06211.x

Zhang, 2007, Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43, J Neurosci, 27, 10530, 10.1523/JNEUROSCI.3421-07.2007

Fuentealba, 2010, Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43, J Biol Chem, 285, 26304, 10.1074/jbc.M110.125039

Furukawa, 1812, Molecular properties of TAR DNA binding protein-43 fragments are dependent upon its cleavage site, Biochim Biophys Acta, 2011, 1577

Yang, 2010, The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism, PLoS One, 5, e15878, 10.1371/journal.pone.0015878

Che, 2011, Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing, FASEB J, 25, 2344, 10.1096/fj.10-174482

Voigt, 2010, TDP-43-mediated neuron loss in vivo requires RNA-binding activity, PLoS One, 5, e12247, 10.1371/journal.pone.0012247

Pesiridis, 2011, A “two-hit” hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport, J Biol Chem, 286, 18845, 10.1074/jbc.M111.231118

Van Langenhove, 2012, The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum, Ann Med, 44, 817, 10.3109/07853890.2012.665471

Tsuiji, 2013, Spliceosome integrity is defective in the motor neuron diseases ALS and SMA, EMBO Mol Med, 5, 221, 10.1002/emmm.201202303

Jackrel, 2014, Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events, Cell, 156, 170, 10.1016/j.cell.2013.11.047

Gregory, 2012, The aggregation and neurotoxicity of TDP-43 and its ALS-associated 25 kDa fragment are differentially affected by molecular chaperones in Drosophila, PLoS One, 7, e31899, 10.1371/journal.pone.0031899

Crippa, 2010, A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases, Autophagy, 6, 958, 10.4161/auto.6.7.13042

Hasegawa, 2008, Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Ann Neurol, 64, 60, 10.1002/ana.21425

Inukai, 2008, Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS, FEBS Lett, 582, 2899, 10.1016/j.febslet.2008.07.027

Neumann, 2009, Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies, Acta Neuropathol, 117, 137, 10.1007/s00401-008-0477-9

Kametani, 2009, Identification of casein kinase-1 phosphorylation sites on TDP-43, Biochem Biophys Res Commun, 382, 405, 10.1016/j.bbrc.2009.03.038

Iguchi, 2012, Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies, Neurobiol Dis, 45, 862, 10.1016/j.nbd.2011.12.002

Li, 2011, Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation, PLoS One, 6, e23075, 10.1371/journal.pone.0023075

Brady, 2011, Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1, J Neurochem, 116, 248, 10.1111/j.1471-4159.2010.07098.x

Choksi, 2014, TDP-43 Phosphorylation by casein kinase Iepsilon promotes oligomerization and enhances toxicity in vivo, Hum Mol Genet, 23, 1025, 10.1093/hmg/ddt498

Salado, 2014, Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis, J Med Chem, 57, 2755, 10.1021/jm500065f

Seyfried, 2010, Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains, Mol Cell Proteomics, 9, 705, 10.1074/mcp.M800390-MCP200

Hans, 2014, UBE2E ubiquitin-conjugating enzymes and ubiquitin isopeptidase Y regulate TDP-43 protein ubiquitination, J Biol Chem, 289, 19164, 10.1074/jbc.M114.561704

Wenqiang, 2014, Parkin-mediated reduction of nuclear and soluble TDP-43 reverses behavioral decline in symptomatic mice, Hum Mol Genet, 23, 4960, 10.1093/hmg/ddu211

Gray, 2003, Ubiquitin, proteasomes, and the aging brain, Sci Aging Knowledge Environ, 2003, RE6, 10.1126/sageke.2003.34.re6

Majounie, 2012, Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study, Lancet Neurol, 11, 323, 10.1016/S1474-4422(12)70043-1